Vir Biotechnology, Inc. (VIR)
| Previous close | 9.93 |
| Open | 9.76 |
| Bid | 9.63 x 200 |
| Ask | 9.69 x 400 |
| Day's range | 9.60 - 9.89 |
| 52-week range | 7.61 - 27.48 |
| Volume | |
| Avg. volume | 1,050,104 |
| Market cap | 1.314B |
| Beta (5Y monthly) | 0.41 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -4.01 |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 32.29 |
Simply Wall St.Analysts Just Shipped A Stunning Upgrade To Their Vir Biotechnology, Inc. (NASDAQ:VIR) Estimates
Shareholders in Vir Biotechnology, Inc. ( NASDAQ:VIR ) may be thrilled to learn that the analysts have just delivered a...
ZacksWall Street Analysts Think Vir Biotechnology (VIR) Could Surge 188.65%: Read This Before Placing a Bet
The average of price targets set by Wall Street analysts indicates a potential upside of 188.7% in Vir Biotechnology (VIR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Insider MonkeyVir Biotechnology, Inc. (NASDAQ:VIR) Q1 2024 Earnings Call Transcript
Vir Biotechnology, Inc. (NASDAQ:VIR) Q1 2024 Earnings Call Transcript May 3, 2024 Vir Biotechnology, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello. Welcome to Vir Biotechnology’s First Quarter 2024 Financial Results and Business Update Call. As a reminder, […]
